Target intelligence / Profile preview

Novel transcript, antisense to WNT2B (ENSG00000273483)

Target
ENSG00000273483
Molecular classification
Long non-coding RNA (lncRNA), Natural antisense transcript (NAT), Other
01

Overview

Novel transcript, antisense to WNT2B" (ENSG00000273483) is a **long non-coding RNA gene** oriented antisense to the WNT2B gene. Natural antisense transcripts like this are widespread in eukaryotic genomes and function mainly to regulate the expression of their corresponding sense genes. Mechanisms include transcriptional interference, RNA masking, formation of double-stranded RNA, and chromatin modification. These processes may impact the transcription, splicing, stability, or translation efficiency of the WNT2B gene, though specific roles of this antisense transcript remain uncharacterized in the literature[1][2][3][4][5]. This transcript is not an established druggable target and has no known direct links to any diseases or drugs. Its regulatory influence exemplifies the complex role of non-coding RNAs in gene expression and epigenetic regulation.

Other names
Novel transcript, antisense to WNT2B
02

Mechanism of action

Not applicable for therapeutics. Mechanistically, as a NAT, it may regulate gene expression by: - Transcriptional interference (inhibiting sense transcript) - RNA masking (modifying RNA stability or splicing) - Chromatin remodeling (altering the chromatin state near the sense gene) - Potential RNA interference pathways

03

Biological functions

Regulation of gene expression (cis or trans regulation of the overlapping WNT2B gene and possibly other genes)Chromatin modification/co-transcriptional regulationRNA masking (can interfere with splicing or stability of the sense transcript)Transcriptional interference
04

Disease associations

Other (as a NAT, could play a role in diseases through dysregulation of WNT2B, but there is no direct link for this specific transcript)No direct evidence for roles in cancer, inflammation, etc. specific to this transcript in current public data

Beyond the preview

Go deeper on Novel transcript, antisense to WNT2B (ENSG00000273483).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to WNT2B (ENSG00000273483).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call